Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ferrara

Showing results (431-440 of 435) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 435 results.
Medrxiv : the Preprint Server for Health Sciences|July 24, 2020
Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19Stuart P Weisberg, Thomas Connors, Yun Zhu, et al.
European Review for Medical and Pharmacological Sciences|April 25, 2020
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experienceF Diurno, F G Numis, G Porta, et al.
Nature Immunology|November 6, 2020
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrumStuart P Weisberg, Thomas J Connors, Yun Zhu, et al.
Experimental Astronomy|February 14, 2022
Synergies of THESEUS with the large facilities of the 2030s and guest observer opportunitiesP Rosati, S Basa, A W Blain, et al.
The Journal of Clinical Investigation|May 11, 2021
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19Max R O'Donnell, Beatriz Grinsztejn, Matthew J Cummings, et al.
Pageof 44

Showing results (431-440 of 435) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 435 results.
Medrxiv : the Preprint Server for Health Sciences|July 24, 2020
Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19Stuart P Weisberg, Thomas Connors, Yun Zhu, et al.
European Review for Medical and Pharmacological Sciences|April 25, 2020
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experienceF Diurno, F G Numis, G Porta, et al.
Nature Immunology|November 6, 2020
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrumStuart P Weisberg, Thomas J Connors, Yun Zhu, et al.
Experimental Astronomy|February 14, 2022
Synergies of THESEUS with the large facilities of the 2030s and guest observer opportunitiesP Rosati, S Basa, A W Blain, et al.
The Journal of Clinical Investigation|May 11, 2021
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19Max R O'Donnell, Beatriz Grinsztejn, Matthew J Cummings, et al.
Pageof 44